Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.
Publication
, Journal Article
Edelman, MJ; Hodgson, L; Wang, X; Kratzke, RA; Vokes, EE
Published in: J Clin Oncol
June 1, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2012
Volume
30
Issue
16
Start / End Page
2019 / 2020
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Male
- Lung Neoplasms
- Humans
- Female
- Cyclooxygenase 2
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Edelman, M. J., Hodgson, L., Wang, X., Kratzke, R. A., & Vokes, E. E. (2012). Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer. J Clin Oncol, 30(16), 2019–2020. https://doi.org/10.1200/JCO.2011.41.4581
Edelman, Martin J., Lydia Hodgson, Xiaofei Wang, Robert A. Kratzke, and Everett E. Vokes. “Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.” J Clin Oncol 30, no. 16 (June 1, 2012): 2019–20. https://doi.org/10.1200/JCO.2011.41.4581.
Edelman MJ, Hodgson L, Wang X, Kratzke RA, Vokes EE. Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer. J Clin Oncol. 2012 Jun 1;30(16):2019–20.
Edelman, Martin J., et al. “Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.” J Clin Oncol, vol. 30, no. 16, June 2012, pp. 2019–20. Pubmed, doi:10.1200/JCO.2011.41.4581.
Edelman MJ, Hodgson L, Wang X, Kratzke RA, Vokes EE. Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer. J Clin Oncol. 2012 Jun 1;30(16):2019–2020.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2012
Volume
30
Issue
16
Start / End Page
2019 / 2020
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Male
- Lung Neoplasms
- Humans
- Female
- Cyclooxygenase 2
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis